(HealthDay) —Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in people five years and older, the agency said Thursday in a news release.
Feb 9, 2017
The use of recreational amphetamine, popularly known as 'speed,' 'ice,' and 'ecstasy,' may hasten the biological ageing of the heart, suggests research, published in the online journal Heart Asia.
Feb 9, 2017
A small but clinically important trial of a new ultra-low dose four-in-one pill to treat high blood pressure has produced remarkable results.
Feb 9, 2017
Some people in mental health units should be allowed to continue to injure themselves as part of a harm reduction regime, says a researcher with experience of mental health care in the Journal of Medical Ethics.
Feb 9, 2017
